fda glp-1 compounding crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA proposes a new GLP-1

Clinicians should consider individual patient factors and monitor for changes, especially in those with existing arrhythmias

Your 7-Day Meal Plan Preview ~1,500 calories daily with 100g+ protein

How do IVF success rates compare with hCG trigger versus other methods

J Physiol Pharmacol , 60(Suppl 7), 191-96

The sequence corresponds to a fragment originally identified within a larger protein derived from gastric tissue, and it is studied as an isolated peptide with consistent physicochemical characteristics

It features a naturally occurring, amidated C-terminal modification (-NH) that enhances its stability as well as biological function